1Q Health Group has acquired 100% of EHF Group, a leading contract development and manufacturing organisation (CDMO) based in Capelle aan den IJssel.

This acquisition marks the exit of IVY Capital and brings together EHF Group’s expertise in product development and manufacturing with 1QHealth Group’s strategy to build a pan-European nutraceuticals and CDMO platform, backed by NORD Holding. The partnership enables both organisations to offer complementary dosage forms and product ranges, expand their reach across Europe, and accelerate innovation in the health and nutrition sector.

The transaction reflects continued consolidation in the CDMO sector and the ongoing growth of the European market for vitamins, minerals, and supplements. Demand for high-quality, compliant manufacturing and omni-channel distribution continues to rise, driven by consumer trends and the increasing focus on health and well being.

EHF Group is known for operating a modern IFS-certified productionfacility offering tableting, encapsulation, powders, and dispensingsolutions, alongside its offering of premium health and nutritionbrands, including Fittergy and Sportvasten. EHF Group also maintainsa strong e-commerce presence through several high-quality domainnames. The management team remains committed and invested in thebusiness following the transaction.

The IMAP Netherlands deal team, consisting of Balthazar den Breems, Kevin Weij, Rens Wisman and Dirk Lam, advised EHF Group on the transaction.